Antimycin A1 (CAS 642-15-9)

Antimycin A1, a member of the antimycin family, is a potent inhibitor primarily known for its specific action on the mitochondrial electron transport chain. It acts at the bc1 complex (Complex III), where it binds to the Q_i site of cytochrome b, thereby preventing electron transfer from ubiquinol to cytochrome c1. This inhibition leads to a disruption in the proton gradient and, consequently, a halt in ATP synthesis via oxidative phosphorylation. Due to its ability to block electron flow and induce reactive oxygen species (ROS) production, Antimycin A1 has been extensively utilized in biochemical research to study cellular respiration, energy metabolism, and the mechanisms underlying ROS generation. Its role in inducing mitochondrial dysfunction makes it a valuable tool in investigations of cellular responses to mitochondrial stress and the regulation of apoptosis, independent of its potential implications in healthcare. Researchers have also exploited the unique properties of Antimycin A1 to explore the broader physiological roles of mitochondria in cellular signaling and adaptation to metabolic stress, providing insights that extend far beyond its initial characterization as an inhibitor of mitochondrial function.